Old Web
English
Sign In
Acemap
>
authorDetail
>
U. J. Scheuring
U. J. Scheuring
Interferon
Sorafenib
Internal medicine
Oncology
Medicine
3
Papers
192
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparison of kidney cancer symptoms and quality of life (QoL) in renal cell cancer (RCC) patients (pts) receiving sorafenib vs interferon-α (IFN)
2008
Journal of Clinical Oncology
Cezary Szczylik
David Cella
T. Eisen
Sonalee Shah
Nicole Laferriere
U. J. Scheuring
B. Escudier
Show All
Source
Cite
Save
Citations (8)
Randomized phase II trial of first-line treatment with sorafenib versus interferon in patients with advanced renal cell carcinoma: Final results
2007
Journal of Clinical Oncology
Cezary Szczylik
Tomasz Demkow
Michael Staehler
F. Rolland
S. Negrier
Thomas E. Hutson
Ronald M. Bukowski
U. J. Scheuring
K. Burk
Bernard Escudier
Show All
Source
Cite
Save
Citations (128)
Randomized phase II trial of the multi-kinase inhibitor sorafenib versus interferon (IFN) in treatment-naive patients with metastatic renal cell carcinoma (mRCC)
2006
Journal of Clinical Oncology
Bernard Escudier
Cezary Szczylik
Tomasz Demkow
Michael Staehler
F. Rolland
S. Negrier
Thomas E. Hutson
U. J. Scheuring
Brian S. Schwartz
Ronald M. Bukowski
Show All
Source
Cite
Save
Citations (56)
1